Go Pro

Tema Oncology ETF (CANC) Holdings List

$42.01 +0.37 (+0.89%)
Closing price 03:59 PM Eastern
Extended Trading
$42.00 -0.02 (-0.04%)
As of 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

What stocks does CANC hold?

The Tema Oncology ETF (CANC) has 61 holdings, with Revolution Medicines, Cogent Biosciences, and Merck & Co., Inc. among its largest positions. The top 25 CANC holdings ordered by weight make up 75.35% of the total fund. CANC is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes a complete CANC stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 CANC Holdings

RankCompanyCurrent PriceWeightShares Held
1
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$204.48
+1.4%
5.51%55,664
2
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$31.66
-0.6%
4.87%307,451
3
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$149.30
+0.4%
4.62%66,469
4
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,184.85
+0.0%
4.51%8,209
5Novartis AGN/A3.60%53,535
6
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$62.90
-1.5%
3.55%115,234
7
AbbVie Inc. stock logo
ABBV
AbbVie
$263.54
-1.0%
3.55%27,898
8
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$267.66
-1.6%
3.24%25,055
9
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$365.27
-0.5%
3.19%19,049
10
Roche Holding AG stock logo
RHHBY
Roche
$52.22
-2.2%
3.17%119,440
Bezos… DOOMED (Ad)

A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing December 8th.tc pixel

Watch James Altucher's free video breakdown before the December 8th deadline.
11
Genmab A/S Sponsored ADR stock logo
GMAB
Genmab A/S
$35.57
+0.6%
3.09%187,107
12
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$111.56
-1.2%
3.00%58,493
13
Exelixis, Inc. stock logo
EXEL
Exelixis
$58.65
+0.5%
2.85%103,531
14
CG Oncology, Inc. stock logo
CGON
CG Oncology
$70.52
+1.3%
2.78%79,127
15
Immunome, Inc. stock logo
IMNM
Immunome
$21.89
+1.0%
2.73%235,688
16
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
$37.86
-0.9%
2.64%145,181
17
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
$46.51
+1.1%
2.54%98,433
18
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$65.97
-1.0%
2.44%73,889
19
Erasca, Inc. stock logo
ERAS
Erasca
$14.21
+0.6%
2.12%269,242
20AstraZeneca PLCN/A2.09%26,513
21
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
$18.36
+3.8%
2.06%224,406
22
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
$25.93
+0.9%
1.97%164,578
23
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$14.45
+31.5%
1.75%386,437
24
Celcuity, Inc. stock logo
CELC
Celcuity
$77.38
-2.8%
1.75%43,707
25
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
$18.82
+1.1%
1.73%201,984

CANC Geographic Exposure

CANC's largest geographic exposure is United States at 92.4%, followed by Switzerland at 3.8%.

  • United States
    92.4%
  • Switzerland
    3.8%
  • United Kingdom
    2.1%
  • Israel
    1.2%
  • Netherlands
    0.8%

CANC Currency Exposure

CANC's largest currency exposure is USD at 67.0%, followed by CHF at 3.8%.

  • USD
    67.0%
  • CHF
    3.8%
  • GBP
    2.1%

CANC Sector Exposure

CANC's largest sector exposure is Health Care at 98.1%, followed by Consumer Discretionary at 0.8%.

  • Health Care
    98.1%
  • Consumer Discretionary
    0.8%

CANC Industry Exposure

CANC's largest industry exposure is Biotechnology at 88.0%, followed by Pharmaceuticals at 7.1%.

  • Biotechnology
    88.0%
  • Pharmaceuticals
    7.1%
  • Diversified Consumer Services
    2.5%
  • Health Care Providers & Services
    1.2%

CANC Sub-Industry Exposure

CANC's largest sub-industry exposure is Biotechnology at 79.0%, followed by Pharmaceuticals at 12.9%.

  • Biotechnology
    79.0%
  • Pharmaceuticals
    12.9%
  • Health Care Services
    1.2%

Related Companies and Tools


MarketBeat tracks Tema Oncology ETF holdings and portfolio composition, last updated on 9/17/2026.
From Our Partners